Trials / Unknown
UnknownNCT03436576
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
Comparison of Autologous Serum 20% and Autologous Serum 50% for the Treatment of Severe Dry Eye
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Pontificia Universidad Catolica de Chile · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects of autologous serum 20% and autologous serum 50% for the treatment of Severe Dry Eye Syndrome
Detailed description
To determine the difference between autologous serum 20% vs 50%, in terms of improvement of symptoms, improvement of ocular surface parameters and acceptable tolerability in patients with severe dry eye syndrome.
Conditions
- Dry Eye
- Keratoconjunctivitis Sicca
- Sjogren's Syndrome
- Corneal Diseases
- Conjunctival Diseases
- Keratitis
- Lacrimal Apparatus Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Autologous Serum 20% | Instillation of 1 drop of Autologous Serum 20% four times a day |
| DRUG | Autologous Serum 50% | Instillation of 1 drop of Autologous Serum 50% four times a day |
Timeline
- Start date
- 2018-09-12
- Primary completion
- 2018-10-19
- Completion
- 2018-11-19
- First posted
- 2018-02-19
- Last updated
- 2018-09-05
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT03436576. Inclusion in this directory is not an endorsement.